Showing results (301-310 of 760) with videos related to
Sort By:
Pageof 76
JCI Insight|February 8, 2023
Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myelomaJana Jakubikova, Danka Cholujova, Gabor Beke, et al.Blood|January 17, 2013
Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humansGüllü Topal Görgün, Gregory Whitehill, Jennifer L Anderson, et al.Haematologica|July 5, 2006
Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib aloneSundar Jagannath, Paul G Richardson, Bart Barlogie, et al.Blood|September 16, 2004
Patupilone (epothilone B) inhibits growth and survival of multiple myeloma cells in vitro and in vivoBoris Lin, Laurence Catley, Richard LeBlanc, et al.Proteomics|March 3, 2011
A novel panel of protein biomarkers for predicting response to thalidomide-based therapy in newly diagnosed multiple myeloma patientsRajesh Rajpal, Paul Dowling, Justine Meiller, et al.Blood|June 26, 2004
VEGF induces Mcl-1 up-regulation and protects multiple myeloma cells against apoptosisSteven Le Gouill, Klaus Podar, Martine Amiot, et al.Blood|May 14, 2009
Bortezomib induces canonical nuclear factor-kappaB activation in multiple myeloma cellsTeru Hideshima, Hiroshi Ikeda, Dharminder Chauhan, et al.Clinical Lymphoma, Myeloma & Leukemia|July 7, 2020
Primary Plasma Cell Leukemia: Real-World Retrospective Study of 46 Patients From a Single-Center Study in ChinaTengteng Yu, Yan Xu, Gang An, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2007
Phenotypic and functional effects of heat shock protein 90 inhibition on dendritic cellJooeun Bae, Constantine Mitsiades, Yu-Tzu Tai, et al.Leukemia|July 22, 2021
Targeting LAG3/GAL-3 to overcome immunosuppression and enhance anti-tumor immune responses in multiple myelomaJooeun Bae, Fabrizio Accardi, Teru Hideshima, et al.Pageof 76